BPA Call 36C25218A0045-36C25218N4657

This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to INO Therapeutics LLC, a company that provides inhaled nitric oxide therapy systems and related medical gases. The contract is for the delivery of NITRIC OXIDE MEDICAL GAS with an ultimate completion date of September 30, 2024 and a ceiling value of $29,571.60. The contract was awarded without a set-aside designation and is under the Pharmaceuticals and Drugs GSA...

This is a firm fixed-price delivery order awarded by the U.S. Medical Command (MEDCOM) to INO Therapeutics LLC, a prime contractor that provides inhaled nitric oxide therapy systems and related medical gases to U.S. government agencies. The $148,092.00 contract is for the delivery of nitric oxide 800PPM gas to support healthcare programs at the San Antonio Military Medical Center (SAMMC). The award was made under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) without any...

This delivery order, awarded by the Department of the Army Medical Command to INO Therapeutics LLC, is for the purchase of nitric oxide respiratory gas from October 1, 2018 through September 30, 2019. The firm fixed price contract, valued at one hundred forty-nine thousand eight hundred ninety dollars and eighty cents ($149,890.80), utilizes the Pharmaceuticals and Drugs schedule under the General Services Administration (GSA) multiple award schedule contracts to acquire the product, with...

This is a delivery order awarded by the Department of Veterans Affairs (VA) to INO Therapeutics LLC, a prime contractor that provides inhaled nitric oxide therapy systems and related medical gases to VA hospitals and clinics. The $372,418.70 firm-fixed-price contract, which is part of the VA's Pharmaceuticals and Drugs GSA Schedule 61 contract, is for the delivery of inhaled nitric oxide to improve oxygenation in term and near-term neonates. This is not a set-aside contract. INO Therapeutics has...

This is a delivery order awarded by the National Institutes of Health (NIH) to INO Therapeutics LLC, a foreign-owned for-profit organization. The $248,887.20 fixed-price contract is for the delivery of inhaled nitric oxide therapy systems and related medical gases to support respiratory treatments and healthcare programs for veterans, service members, and military beneficiaries. The contract was awarded under the General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply...

This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to INO Therapeutics LLC, a small business prime contractor, to provide NITRIC OXIDE GAS PRODUCT AS USED FOR INHALATION THERAPY. The contract is a Delivery Order under the Pharmaceuticals and Drugs GSA Schedule, with a Firm Fixed Price pricing type and a ceiling value of $140,001.12. The contract has a Period of Performance from October 1, 2015 to September 30, 2016 and is designated as a Total Small Business...

This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to INO Therapeutics LLC, a foreign-owned, for-profit organization. The contract is for the delivery of NITRIC OXIDE INHALATION GAS with a potential value of $579,350.18. The contract was awarded without a set-aside designation and is a Delivery Order under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB). INO Therapeutics is the prime contractor and has been awarded over...

This is a delivery order contract awarded by the Veterans Integrated Service Network 15 (VISN 15), which is part of the U.S. Department of Veterans Affairs (VA), to INO Therapeutics LLC for the provision of nitric oxide. The contract has a ceiling value of $183,719.44 and a performance period through August 31, 2022. INO Therapeutics is the prime contractor, and the contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) without any set-aside designation. The...

This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to INO Therapeutics LLC, a veteran-owned small business. The contract, worth $210,000.00, is for the supply of nitric oxide gases under the VA's Pharmaceuticals and Drugs GSA Schedule contract. The contract has an ultimate completion date of September 30, 2016. INO Therapeutics LLC is the prime contractor and has previously been awarded over 50 federal contracts to provide inhaled nitric oxide...

This is a Delivery Order contract awarded by the Defense Health Agency (DHA) to INO Therapeutics LLC, a prime contractor, to provide Nitric Oxide Therapy Services. The contract is a Firm Fixed Price arrangement valued at $295,518.66 and has an ultimate completion date of September 30, 2025. It was awarded on January 1, 2021 under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) without any set-aside designation. INO Therapeutics is a foreign-owned, for-profit organization that has...